胃康灵联合奥美拉唑治疗慢性浅表性胃炎的疗效观察

Efficacy observation on treating chronic superficial gastritis with the Weikang Ling plus Omeprazole

目的:探讨胃康灵联合奥美拉唑对慢性浅表性胃炎患者的治疗效果。方法:选择128例慢性浅表性胃炎患者作为研究对象,随机分为治疗组(65例)和对照组(63例)。对照组患者给予奥美拉唑治疗,观察组患者给予胃康灵联合奥美拉唑治疗,疗程均为4周,观察两组患者的疗效、6个月复发以及治疗期间不良反应的发生情况。结果:治疗组患者治疗总有效率(61例,93.85%)高于对照组(52例,82.54%),差异有统计学意义(P<0.05);治疗组患者6个月复发率(7例,10.77%)和不良反应发生率(2例,3.08%)均低于对照组,差异有统计学意义(P<0.05)。结论:胃康灵联合奥美拉唑治疗慢性胃炎患者的效果较好,且复发率和不良反应少。

Objective: To explore efficacy of the Weikang Ling plus Omeprazole on chronic superficial gastritis. Methods: 128 cases of chronic superficial gastritis were randomly divided into the treatment group (65 cases), which received Omeprazole and control group (63 cases), which received the Weikang Ling more, for 4 weeks. Efficacy, palindromia with 6 months following up and adverse reactions duiring treatment were observed. Results:The total efficiency in the treatment group (61 cases, 93.85%) was higher than that in the control group (52 cases, 82.54%), with statistically significant difference (P<0.05). The efficiency of recurrence after 6 months (7 cases, 10.77%) and adverse reactions (2 cases, 3.08%) in the treatment group were lower than that in the control group, with statistically significant difference (P<0.05). Conclusion: Efficacy of Weikang Ling plus omeprazole on chronic superficial gastritis was good at recurrence and adverse reactions.